• 专利标题:   Brain-targeting graphene quantum dot useful in preparation of medicine for e.g. treating Parkinson disease, obtained by performing amidation reaction of graphene quantum dot and brain-targeting peptide.
  • 专利号:   CN114887067-A
  • 发明人:   GUO R
  • 专利权人:   GUANGZHOU BEOGENE BIOTECHNOLOGY CO LTD
  • 国际专利分类:   A61K031/7088, A61K047/04, A61K047/42, A61K049/00, A61P025/16, C01B032/184
  • 专利详细信息:   CN114887067-A 12 Aug 2022 A61K-047/04 202291 Chinese
  • 申请详细信息:   CN114887067-A CN10451712 27 Apr 2022
  • 优先权号:   CN10451712

▎ 摘  要

NOVELTY - Brain-targeting graphene quantum dot is obtained by performing amidation reaction of graphene quantum dot and brain-targeting peptide. USE - The brain-targeting graphene quantum dot is useful in preparation of medicine for treating Parkinson disease (claimed) and high-efficiency loading and targeted delivery of lncRNA-Hh. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for the following: brain-targeting graphene quantum dot gene complex comprising the brain-targeting graphene quantum dot and long non-coding RNA (lncRNA)-Hh, where the lncRNA-Hh comprises a 4394 base pair sequence (SEQ ID NO: 1) fully defined in the specification; preparation method of brain-targeting graphene quantum dot involves preparing graphene quantum dot solution, adding 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) to activate, adding brain targeting peptide, stirring and reacting, dialyzing and freeze-drying product; and preparation method of the brain-targeting graphene quantum dot gene complex involves mixing the brain targeting graphene quantum dot with the plasmid comprising lncRNA-Hh.